Analyst Ratings for Sagent Pharmaceuticals (SGNT) [Neutrals]
SGNT Rating Summary
SGNT Price Target Summary
- Highest: $27.00 (Capstone Investments)
- Lowest: $16.00 (RBC Capital)
- Average: $21.56
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.56 (+32.4%)
Avg. $ Target:
$21.56 (+32.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/18/2012 | Guggenheim | New Coverage | Neutral (N/A) |
16.00 (N/A) |
16.46 | 16.28 | -1.09% | Details |
| 8/13/2012 | Morgan Stanley | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
13.21 | 16.28 | 23.24% | Details |
| 8/10/2012 | RBC Capital | Downgrade | Sector Perform (Outperform) |
16.00 (24.00) |
13.25 | 16.28 | 22.87% | Details |
| 9/28/2011 | JPMorgan | New Coverage | Neutral (N/A) |
25.00 (N/A) |
20.96 | 16.28 | -22.33% | Details |
| 5/31/2011 | BofA/Merrill Lynch | New Coverage | Neutral (N/A) |
N/A (N/A) |
25.21 | 16.28 | -35.42% | Details |
